MCK Stock Overview
McKesson Corporation provides healthcare services in the United States and internationally.
McKesson Corporation Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$381.64|
|52 Week High||US$401.78|
|52 Week Low||US$226.07|
|1 Month Change||-2.34%|
|3 Month Change||4.21%|
|1 Year Change||65.40%|
|3 Year Change||165.16%|
|5 Year Change||142.77%|
|Change since IPO||2,212.97%|
Recent News & Updates
An Intrinsic Calculation For McKesson Corporation (NYSE:MCK) Suggests It's 50% UndervaluedSep 19
Is McKesson Corporation (NYSE:MCK) Trading At A 47% Discount?Mar 10
McKesson (NYSE:MCK) Is Increasing Its Dividend To US$0.47Nov 01
McKesson's (NYSE:MCK) Upcoming Dividend Will Be Larger Than Last Year'sAug 17
McKesson (NYSE:MCK) Will Pay A Larger Dividend Than Last Year At US$0.47Aug 03
Does McKesson (NYSE:MCK) Have A Healthy Balance Sheet?Aug 02
Is McKesson (NYSE:MCK) A Risky Investment?Apr 07
Should McKesson (NYSE:MCK) Be Disappointed With Their 34% Profit?Mar 17
Why It Might Not Make Sense To Buy McKesson Corporation (NYSE:MCK) For Its Upcoming DividendFeb 24
How Much Are McKesson Corporation (NYSE:MCK) Insiders Taking Off The Table?Feb 16
|MCK||US Healthcare||US Market|
Return vs Industry: MCK exceeded the US Healthcare industry which returned 7% over the past year.
Return vs Market: MCK exceeded the US Market which returned -19.6% over the past year.
|MCK Average Weekly Movement||3.7%|
|Healthcare Industry Average Movement||8.1%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.5%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: MCK is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: MCK's weekly volatility (4%) has been stable over the past year.
About the Company
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS).
McKesson Corporation Fundamentals Summary
|MCK fundamental statistics|
Is MCK overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|MCK income statement (TTM)|
|Cost of Revenue||US$259.21b|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||14.54|
|Net Profit Margin||0.76%|
How did MCK perform over the long term?See historical performance and comparison